Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
CBAY

Overview Financials Analysis Smart Money

CymaBay Therapeutics, Inc.

CBAY · NASDAQ

Analyze with AI

Filings2

Total reported value$0.0

Manager	Shares	Value	Change
CREDIT SUISSE AG/	0	$0.0	+100.0%
Cetera Advisors LLC	0	$0.0	+100.0%

SymbolCBAY

Market Cap$3.7B

IPO Date2014-02-03

CEOSujal A. Shah

Employees101

SectorHealthcare

IndustryBiotechnology

CountryUS

ExchangeNASDAQ Global Select

Luminar Technologies, Inc.

LAZR

$0.6044

+174.73%

NovaBay Pharmaceuticals, Inc.

NBY

$5.30

+79.66%

Mint Incorporation Limited

MIMI

$0.4795

+75.45%

Autozi Internet Technology (Global) Ltd.

AZI

$2.50

+64.47%

GD Culture Group Limited

GDC

$5.26

+51.59%

Peers

RayzeBio, Inc. Common Stock

RYZB · NASDAQ

$62.49

+0.02%

SpringWorks Therapeutics, Inc.

SWTX · NASDAQ

$46.99

+0.02%

Mirati Therapeutics, Inc.

MRTX · NASDAQ

$58.70

-0.17%

Opthea Limited

OPT · NASDAQ

$3.41

+1.49%

Morphic Holding, Inc.

MORF · NASDAQ

$56.99

+0.04%

MorphoSys AG

MOR · NASDAQ

$18.96

+2.43%

Chinook Therapeutics, Inc.

KDNY · NASDAQ

$40.39

+0.22%

Alpine Immune Sciences, Inc.

ALPN · NASDAQ

$64.97

+0.02%

Myovant Sciences Ltd.

MYOV · NYSE

$26.98

-0.04%

Longboard Pharmaceuticals, Inc.

LBPH · NASDAQ

$59.98

0.00%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.